ask="8.00"
ask_size="100"
average_daily_volume="119923"
bid="3.84"
bid_size="100"
book_value="2.54"
change="-0.26"
change_from_200_day_moving_average="-0.84"
change_from_50_day_moving_average="0.06"
change_from_52_week_high="-7.24"
change_From_52_week_low="0.59"
change_in_percent="-5.64%"
close="4.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="-74.76M"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-1.20"
ex_dividend_date="N/A"
float_shares="24541000"
high="4.64"
high_52_weeks="11.59"
last_trade_date="3/6/2017"
last_trade_price="4.35"
last_trade_size="200"
last_trade_time="4:00pm"
low="4.22"
low_52_weeks="3.76"
market_capitalization="307.91M"
moving_average_200_day="5.19"
moving_average_50_day="4.29"
name="Adaptimmune Therapeutics plc"
notes="N/A"
one_year_target_price="14.83"
open="4.57"
pe_ratio="N/A"
peg_ratio="0.30"
percent_change_from_200_day_moving_average="-16.24%"
percent_change_from_50_day_moving_average="+1.49%"
percent_change_from_52_week_high="-62.46%"
percent_change_from_52_week_low="+15.69%"
previous_close="4.61"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.81"
price_per_sales="34.26"
revenue="9.52M"
shares_outstanding="70785000"
short_ratio="4.56"
stock_exchange="NMS"
symbol="ADAP"
volume="176349"
weeks_range_52="3.76 - 11.59"
